T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Sweetgreen
SG
$721M
| $34.5M | ﹤0.01% |
4,322,219
-2,235,473
| -34% | -$24.3M |
|
902
Oric Pharmaceuticals
ORIC
$1.42B
| $34.5M | ﹤0.01% |
2,871,327
+108,412
| +4% | +$1.14M |
|
903
Monte Rosa Therapeutics
GLUE
$1.35B
| $34.4M | ﹤0.01% |
4,637,060
-1,688,598
| -27% | -$8.94M |
|
904
Prestige Consumer Healthcare
PBH
$2.43B
| $34.2M | ﹤0.01% |
547,865
+16,256
| +3% | +$1.13M |
|
905
Sportradar
SRAD
$4.02B
| $34.1M | ﹤0.01% |
+1,269,245
| New | +$37.6M |
|
906
Citizens Financial Group
CFG
$31.2B
| $33.8M | ﹤0.01% |
636,147
-2,575
| -0.4% | -$128K |
|
907
Churchill Downs
CHDN
$6.2B
| $33.7M | ﹤0.01% |
347,808
+53,859
| +18% | +$5.54M |
|
908
Rollins
ROL
$17.4B
| $33.6M | ﹤0.01% |
572,407
+4,446
| +0.8% | +$253K |
|
909
W.R. Berkley
WRB
$26.2B
| $33.6M | ﹤0.01% |
438,818
+2,088
| +0.5% | +$149K |
|
910
Warby Parker
WRBY
$3.2B
| $33.5M | ﹤0.01% |
1,213,433
+1,144,309
| +1,655% | +$28.9M |
|
911
Wheaton Precious Metals
WPM
$59.9B
| $33.2M | ﹤0.01% |
297,261
-64,869
| -18% | -$6.34M |
|
912
Lyft
LYFT
$6.48B
| $33.2M | ﹤0.01% |
1,508,209
+822,459
| +120% | +$13.8M |
|
913
Service Corp International
SCI
$11.3B
| $33.1M | ﹤0.01% |
397,250
+57,592
| +17% | +$4.6M |
|
914
Waters Corp
WAT
$40.6B
| $33M | ﹤0.01% |
110,056
+24,044
| +28% | +$7.26M |
|
915
Invesco
IVZ
$14.3B
| $33M | ﹤0.01% |
1,436,526
+198,759
| +16% | +$4.13M |
|
916
Devon Energy
DVN
$48.8B
| $32.9M | ﹤0.01% |
938,421
-44,437
| -5% | -$1.51M |
|
917
Palomar
PLMR
$3.37B
| $32.8M | ﹤0.01% |
280,881
-65,695
| -19% | -$8.33M |
|
|
RAPP
918
Rapport Therapeutics
RAPP
$2.27B
| $32.7M | ﹤0.01% |
1,102,391
-423,128
| -28% | -$7.55M |
|
919
Grupo Aeroportuario del Sureste
ASR
$8.01B
| $32.7M | ﹤0.01% |
101,245
+3,998
| +4% | +$1.29M |
|
920
Ryman Hospitality Properties
RHP
$7.87B
| $32.4M | ﹤0.01% |
361,749
+4,396
| +1% | +$430K |
|
921
Huron Consulting
HURN
$2.47B
| $32.3M | ﹤0.01% |
220,003
+113,102
| +106% | +$15.4M |
|
922
T. Rowe Price
TROW
$23.7B
| $32.2M | ﹤0.01% |
313,348
-2,173
| -0.7% | -$228K |
|
923
Zai Lab
ZLAB
$2.92B
| $32.2M | ﹤0.01% |
948,671
+795,634
| +520% | +$27.4M |
|
|
SF
924
Stifel
SF
$12.9B
| $32M | ﹤0.01% |
422,663
+55,299
| +15% | +$4.14M |
|
925
Blue Owl Capital
OWL
$19.7B
| $31.9M | ﹤0.01% |
1,884,154
+128,982
| +7% | +$2.45M |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.